Christoph Kapitza

Lower Within-Subject Variability of Insulin Detemir in Comparison to NPH Insulin and Insulin Glargine in People With Type 1 Diabetes

Tim Heise, Leszek Nosek, Birgitte Rønn et al. · Diabetes · 2004 · 619 citations · Full text

Medicine, Endocrinology, Pharmacokinetics +17

Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial

Juris J. Meier, Julio Rosenstock, Agnès Hincelin-Méry et al. · Diabetes Care · 2015 · 258 citations

Medicine, Pharmacology, Pharmacotherapy +17

Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin

Christoph Kapitza, Thomas Först, Hans Veit Coester et al. · Diabetes Obesity and Metabolism · 2013 · 190 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes

Michael Horowitz, Anne Flint, Karen L. Jones et al. · Diabetes Research and Clinical Practice · 2012 · 176 citations

Medicine, Endocrinology, Pharmacology +15

Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial

Jort Kropff, Pratik Choudhary, Sankalpa Neupane et al. · Diabetes Care · 2016 · 170 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +17